These trends were particularly contrasting in the plasma profile since all the markers quantified in plasma i.e. NRP-1, VEGF, TGFβ1 and PlGF indicated opposing trends in early onset breast cancer vs older cases, with comparable variability in both healthy controls and breast cancer cases. This evidence concerns the gene NRP1 and breast cancer.